Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 5/20 | 0.55 |
| ▸ | RAB9A | P51151 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.53 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.53 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6859262 | 0.84 | CYP1A2 (0.64) | CYP1A2HPGDCYP2C19MEN1KMT2A | |
| SCHEMBL10458447 | 0.84 | KDM4E (0.72) | CYP1A2HPGDCYP2C19MEN1KMT2A | |
| SCHEMBL2094293 | 0.83 | MEN1 (0.69) | CYP1A2HPGDMEN1KMT2ANPC1 | |
| SCHEMBL2175829 | 0.82 | CYP1A2 (0.75) | CYP1A2HPGDCYP2C19MEN1KMT2A | |
| SCHEMBL29537172 | 0.82 | CYP1A2 (0.75) | CYP1A2HPGDCYP2C19MEN1KMT2A | |
| SCHEMBL2097652 | 0.82 | CYP1A2 (0.62) | CYP1A2HPGDCYP2C19MEN1KMT2A | |
| SCHEMBL9311985 | 0.80 | KMT2A (0.75) | CYP1A2HPGDCYP2C19MEN1KMT2A | |
| Fluoride SCHEMBL11753083 | 0.80 | CYP1A2 (0.60) | CYP1A2HPGDCYP2C19MEN1KMT2A | |
| SCHEMBL646296 | 0.80 | HPGD (0.66) | CYP1A2HPGDCYP2C19MEN1KMT2A | |
| SCHEMBL5188311 | 0.80 | CYP1A2 (0.60) | CYP1A2HPGDCYP2C19MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4960874-A | DYEING CELLULOSE ESTERS AND POLYESTERS | BASF AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | claimed |
| US-4772292-A | Mixture of yellow disperse dyestuffs containing pyridone disazo dye | CASSELLA AKTIENGESELLSCHAFT (DE) | 1988-09-20 | — | — | US | claimed |
| EP-0087616-B1 | ISOTHIAZOLAZO DYESTUFFS | BASF Aktiengesellschaft (DE) | 1986-02-05 | — | — | EP | claimed |
| EP-0087616-A1 | Isothiazolazo dyestuffs | BASF Aktiengesellschaft (DE) | 1983-09-07 | — | — | EP | claimed |
| US-4154577-A | Uniformly disperse dyed water-swellable cellulosic fibers | BASF AKTIENGESELLSCHAFT (DE) | 1979-05-15 | — | — | US | claimed |
| US-4150943-A | Uniformly dyed water-swellable cellulosic fibers | BASF AKTIENGESELLSCHAFT (DE) | 1979-04-24 | — | — | US | claimed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| CN-100497345-C | 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis | OTSUKA PHARMA CO LTD (JP) | 2009-06-10 | — | — | CN | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| CN-1878777-A | 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis | OTSUKA PHARMA CO LTD (JP) | 2006-12-13 | — | — | CN | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| US-4424154-A | Azo dye having a 3-cyano- or 3-carbamoyl-2,6-diaminopyridine coupling component | BASF AKTIENGESELLSCHAFT (DE) | 1984-01-03 | — | — | US | disclosed |
| EP-0023309-A1 | Disazo dyestuffs of the aminopyridine or aminopyrimidine series and their use in dyeing textile material containing cellulose | BASF Aktiengesellschaft (DE) | 1981-02-04 | — | — | EP | disclosed |
| US-4157893-A | MONO OR DISAZO DYE CONTAINING AN AMINO-SUBSTITUTED PYRIMIDINE RING | BASF AKTIENGESELLSCHAFT (DE) | 1979-06-12 | — | — | US | disclosed |
| US-4154577-A | Uniformly disperse dyed water-swellable cellulosic fibers | BASF AKTIENGESELLSCHAFT (DE) | 1979-05-15 | — | — | US | disclosed |
| US-4150943-A | Uniformly dyed water-swellable cellulosic fibers | BASF AKTIENGESELLSCHAFT (DE) | 1979-04-24 | — | — | US | disclosed |
| US-4146535-A | Azo dyes having a 3-cyano- or 3-carbamoyl-2,6-diamino-pyridine coupling component | BASF AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | CYP1A2 420/4885HPGD 1951/4885CYP2C19 1894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.